CBZ
Click for more information
0.00% 5.2¢ cbio limited

mushrooms, page-7

  1. windsor1
    10 Posts.
    clock Created with Sketch.
    19/06/12
    16:11
    Post #: 10323799
    It was Alan Baker from Retirewell who led the charge that resulted in the international C Bio drug developers all leaving the C Bio board.

    Who does Alan Baker then replace these drug developers with?
    2 engineers who also then invited a lawyer onto the board.
    Just what a biotech company needs to develop a drug.
    Well done Alan.
    You must know a lot about drug development.
    Alan, there are a lot of very angry shareholders out there who hold you and Retirewell responsible for this mess.

    CBZ Price at posting: 6.6¢ Sentiment: None Disclosure: Held
    Likes Created with Sketch. 4  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

RMS Ramelius boosts WA gold portfolio with stake in Spartan
right-arrow Created with Sketch.
SUN ANZ deal to buy Suncorp to go ahead following approval from Treasurer
right-arrow Created with Sketch.
SFX Sheffield Resources achieves milestone production, shipments at Thunderbird, WA
right-arrow Created with Sketch.
NIM Nimy extends sulphide targets at Mons with new anomalies identified
right-arrow Created with Sketch.
NEWS Tenant turnover: Reducing costs and revenue-loss
right-arrow Created with Sketch.
LYC Lynas eyes first dysprosium, terbium HREE production in CY25
right-arrow Created with Sketch.
watchlist Created with Sketch. Add CBZ (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.